News

HealthTree Foundation Innovates AI Clinical Trial Matching System

HealthTree Foundation Innovates AI Clinical Trial Matching System

Transforming Access to Clinical Trials Through AI

The HealthTree Clinical Trial Finder Enhances Patient Matching

The HealthTree Foundation has made significant strides in revolutionizing the way blood cancer patients connect with clinical trials. The latest enhancements to their AI-powered Clinical Trial Finder are particularly impactful, matching patients to trials that are ideally suited to their individual medical histories and characteristics.

This month, in honor of Blood Cancer Awareness, the HealthTree Foundation announced a key upgrade to its clinical trial matching tool. Originally focused on multiple myeloma, the HealthTree Clinical Trial Finder has now been expanded to include all types of blood cancers. This means that patients suffering from various forms of leukemia, lymphoma, and myeloproliferative neoplasms can now benefit from this innovative tool.

How the HealthTree Clinical Trial Finder Works

The Clinical Trial Finder employs advanced artificial intelligence techniques to analyze patient medical records, automating the complex task of determining eligibility requirements for clinical trials. One notable feature of this upgrade includes the AI-driven calculation of previous treatment lines directly from patient records. This is critical because eligibility criteria can often be intricate and challenging to interpret from traditional electronic health records.

While navigating clinical trial options can be daunting, the HealthTree Clinical Trial Finder simplifies the process. By processing a patient’s unique medical data—ranging from treatment histories to lab test results—the tool provides a personalized list of trials that meet all necessary criteria. This allows patients and their healthcare teams to make well-informed decisions about potential participation in trials that could offer access to groundbreaking therapies.

Personalization at its Core

Jenny Ahlstrom, the founder and CEO of HealthTree, emphasized the uniqueness of their offering, stating, "This is the first truly personalized clinical trial finder. Unlike regular search tools that operate on generic filters such as location or treatment type, we delve into tens of thousands of data points to align patients' real-world medical profiles with suitable trial matches." This commitment to personalization ensures that patients are equipped with the most relevant options available.

Moreover, Juan Pablo Capdevila, the Chief Technology Officer at HealthTree, noted, "Our AI capabilities empower the Clinical Trial Finder with precise, validated, and organized data. This technological advancement facilitates real-time data analysis matched against constantly updated trial databases, ensuring instant and accurate matching outcomes for patients."

Impact on Cancer Treatment Landscape

The HealthTree Clinical Trial Finder does more than just provide a list of trials; it actively enhances the discovery process for new treatments. By accelerating patient enrollment in clinical trials, it fosters the development of new therapies more quickly, ultimately translating into faster cures for various forms of blood cancer.

For patients navigating the complexities of blood cancer treatment options, the HealthTree Clinical Trial Finder emerges as an invaluable resource. It not only enhances access to numerous treatment options but also streamlines time management for healthcare providers, allowing them to direct their energy toward patient care and clinical advancements.

About the HealthTree Foundation

HealthTree Foundation stands at the forefront of innovation in the healthcare sector. As a global nonprofit organization, its mission is clear: to improve patient outcomes and discover cures for blood cancers by leveraging cutting-edge technology and fostering research collaborations. One of the foundation’s standout initiatives is the HealthTree Cure Hub, a powerful data portal where over 14,000 patients contribute their real-world data. This collective effort is aimed at driving significant breakthroughs in cancer treatment, thereby creating a profound impact in the medical community.

HealthTree’s commitment to uniting patients and researchers is pivotal in revolutionizing cancer care. As they continue to expand their resources and tools, all eyes are on the accelerating pace at which they unearth new avenues for treatment and cures.

Frequently Asked Questions

What is the HealthTree Clinical Trial Finder?

The HealthTree Clinical Trial Finder is a personalized tool that matches blood cancer patients to clinical trials based on their unique medical records.

Who can use the Clinical Trial Finder?

The tool is available for all blood cancer patients, including those with leukemia, lymphoma, and myeloproliferative neoplasms.

How does the AI enhance matching for trials?

The AI analyzes vast amounts of patient medical data to ensure accurate trial matching based on established eligibility criteria.

What improvements have been made to the Clinical Trial Finder?

Recent enhancements include automated calculations of prior therapy lines and improved match rates, with detailed explanations provided for patients.

How can patients access the HealthTree Clinical Trial Finder?

Patients can join the HealthTree Cure Hub to utilize the Clinical Trial Finder and connect with various clinical trials.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Encore Boston Harbor Workers Triumph After 62-Day Strike

Updated Category News Views 190

Labor Standoff at Encore Boston Harbor Ends After a stormy 62 days on the picket lines, around 1,300 workers at Encore Boston Harbor finally find themselves back at their posts, carrying with them the spoils of hard-fought victory. This isn't just a paper contract; it's a banner for worker solidarity. These aren't your run-of-the-mill stock flips, folks; this fight was...

Continue Reading
Beverly Hills Body Academy: A New Era in Contouring

Updated Category News Views 30

Setting New Standards in Body Contouring It's no secret that Beverly Hills is all about luxury and cutting-edge trends. So, when the Beverly Hills Body Academy™ (BHBA) sets up shop in this glitzy locale, it's a pretty loud statement in the world of body contouring. This isn't just another vanity-driven operation; it's about pioneering advancements in the field of body...

Continue Reading
Senstar Boasts Robust Q3 Growth Amid Global Demand

Updated Category News Views 150

A Standout Quarter for Senstar Technologies How often do you see a company jumping 37% in revenue year-over-year? Not every day, that’s for sure. But that's exactly what's happening with Senstar Technologies Corporation (NASDAQ: SNT). For the third quarter of 2026, they've pulled in $13.1 million compared to last year’s $9.5 million. And that's not just some fluke –...

Continue Reading
Used Truck Inventory Shrinks as Auction Values Rise

Updated Category News Views 124

October's Tailspin in Used Truck Inventory If you've been around the block in the trucking industry, the latest from Sandhills Global might just knock your socks off. Their October rundown is out, and it's looking bleak for anyone trying to grab a used truck or trailer at a bargain. We're seeing a real crunch in inventory, and that’s an understatement. Navigating a...

Continue Reading
Tenax Sued: Investors Face Class Action Over TNX-103

Updated Category News Views 83

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Continue Reading
F&G Boosts Dividend for Investors in Strong Signal

Updated Category News Views 214

Ring the Bell: Dividend Hike from F&G F&G Annuities & Life (NYSE: FG) just raised its dividend, and every investor worth their salt knows that means something. A 4% bump up to $0.26 per common share might not sound like a fanfare, but in the land of finance, it's an indication that this company thinks it's riding a positive wave. It’s like getting a little bonus in your...

Continue Reading
Esperto's Space Health Tech Eyes Terrestrial Gains

Updated Category News Views 45

The cosmos isn't just a playground for astronauts. It's a proving ground for the next wave of medical innovation, courtesy of Esperto Medical. They're trotting into uncharted territory with the Translational Research Institute for Space Health (TRISH) grant in hand, determined to transform healthcare both in space and on our own turf. Groundbreaking Tech for Extreme...

Continue Reading
Bank of America Faces Class Action for Securities Fraud

Updated Category News Views 97

Bank of America's Costly Missteps So, Bank of America (NYSE:BAC) has managed to paint itself into a corner again—this time with a whopping $1.2 billion fine from the U.S. Department of the Treasury. The buzz isn't great. It’s about violations of anti-money laundering and sanctions laws affecting national security. On October 13, 2026, this filthy laundry was aired,...

Continue Reading
Array Digital's Q3 2026 Earnings: Strategic Wins and Challenges

Updated Category News Views 109

From Towers to Earnings: Array Digital's 2026 Path Array Digital Infrastructure, Inc. (NYSE:AD) just rolled out its Q3 2026 numbers, and honestly, it's a mixed bag. This company is one of those handy barometers for the telecom infrastructure market, especially now that it's a full-blown tower company. They've pitched an earnings call for the early birds at 9 a.m. CT...

Continue Reading
RCMA Makeup Makes Bold Retail Move with Ulta.com Debut

Updated Category News Views 122

RCMA Makeup: A Longstanding Industry Insider You know when a brand’s been around the block since the 60s, it’s got staying power. RCMA Makeup’s been a snug fit in the toolbox of professional makeup artists for over six decades. This ain't some fly-by-night operation. They’ve thrived on word of mouth—no flashy ads or promotional stunts. Just rock-solid reputation...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Mobility Chair Redefines User Experience and Safety

Updated Category News Views 101

Introducing an Innovative Mobility Solution In the quest for improved independence and mobility, an inventive mind has come forth with a groundbreaking solution—the WILLY CHAIR. This innovative mobility chair has been designed with the user's ease and control in mind, enhancing mobility while ensuring safety. Transforming Movement with the WILLY CHAIR The WILLY CHAIR...

Continue Reading
Uncovering May 2025's Leading Mobile Apps Across EMEA Regions

Updated Category News Views 270

Revolutionizing Mobile App Insights in EMEA In recent years, mobile applications have transformed how we communicate, shop, and entertain ourselves. Companies like Pixalate are at the forefront of enhancing the mobile app ecosystem by providing clear insights into the apps that capture user attention the most. The latest rankings showcase the top-performing mobile apps in...

Continue Reading
Empowering Eczema Management: ATOPIYO Launches in the U.S.

Updated Category News Views 156

Empowering Eczema Management: ATOPIYO Launches in the U.S. 11-time award winner, university-backed, delivers what 31M patients need most — visual tracking, peer support, AI analysis Living with eczema goes beyond physical symptoms—it can impact mental well-being and daily life significantly. ATOPIYO, the leading eczema management app from Japan, is now introducing its...

Continue Reading
Integrum's Innovative Marketing Strategy Highlights BondedMatrix

Updated Category News Views 176

Integrum Introduces Global Marketing Strategy at AOPA Assembly Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), a leading provider of the OPRA™ Implant System, has rolled out an innovative global marketing strategy during the American Orthotic & Prosthetic Association's (AOPA) National Assembly. This pivotal initiative emphasizes BondedMatrix™, a term...

Continue Reading
TopGum Welcomes Raviv Zoller as Chairman of the Board

Updated Category News Views 176

TopGum Welcomes Raviv Zoller to Lead as Chairman of the Board Raviv Zoller brings nearly 30 years of international executive experience; his appointment reflects TopGum's commitment to long-term growth plans. TopGum Industries Ltd. (TASE: TPGM), known globally for its innovative gummy-format dietary supplements, has announced the significant appointment of Raviv Zoller as...

Continue Reading